Zura Bio Inc.

Inflammatory Skin Disease

Clinical research in hidradenitis suppurativa focuses on reducing inflammatory lesions and improving disease control in adults living with chronic, recurrent skin involvement. The sponsor’s work in this area centers on therapeutic evaluation for a condition marked by painful nodules, abscesses, and scarring.

  • Hidradenitis suppurativa
  • Inflammatory lesions
  • Chronic dermatologic disease

These studies reflect interest in treatment options for persistent cutaneous inflammation and the clinical burden associated with localized skin disease.

Autoimmune Connective Tissue Disease

Research in systemic sclerosis addresses skin thickening and related manifestations of a fibrosing autoimmune disorder. The sponsor’s trials examine therapeutic effects in a disease that can affect the skin and multiple organ systems.

  • Systemic sclerosis
  • Skin thickening
  • Autoimmune fibrosis

This area highlights interest in conditions where immune dysregulation and progressive tissue remodeling contribute to long-term morbidity.

Immunology and Inflammation

The sponsor’s clinical program is concentrated in immune-mediated disease, with attention to inflammatory pathways that drive both dermatologic and fibrotic disorders. The therapeutic focus spans conditions in which immune activity contributes to persistent tissue damage and symptom burden.

  • Immune-mediated disease
  • Inflammatory pathways
  • Fibrotic disease

These research interests align with therapies intended to address abnormal immune activation in chronic nonmalignant conditions.

Clinical Development in Rare and Chronic Disease

The sponsor is active in clinical development for chronic, specialized conditions with significant unmet need, including disorders managed across multiple research sites and countries. Its portfolio includes studies in diseases that require ongoing assessment of efficacy and tolerability in adult populations.

  • Chronic disease management
  • Adult patient populations
  • Multinational clinical research

Current activity spans multiple regions and site networks supporting research in dermatology and systemic autoimmune disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A study to test if tibulizumab works and is safe for adults with systemic sclerosis

    Not recruiting

    2 1
    Hungary Poland Romania Spain
  • Study of Tibulizumab to Treat Adults with Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Hungary Poland Spain